not tagged
not tagged
['ease']
aging effect on inflammatory process in ms in a way that could diminish the dmts impact and allow for stopping treatment when having a stable disease and on one of the platform injectables. stopping nat and sp1 modulators is risky due to rebound.
#ectrims2022 
Lecturer, Clinical Pharmacy Department, KSU. PhD student, E-health Unit, UCL. Research in Multiple Sclerosis and Decision Aids. ??Opinions shared are my own??